DNAJB9 (also known as ERdj4, ERDJ4, or Mom14) is a member of the DnaJ heat shock protein family, which functions as a co-chaperone in the endoplasmic reticulum (ER). It plays a critical role in protein quality control through its involvement in ER-associated degradation (ERAD) and regulation of the unfolded protein response (UPR). ThisER-lumenal chaperone is essential for maintaining ER homeostasis, particularly in cells that produce large amounts of secreted and membrane proteins, and has been increasingly recognized for its roles in neuronal survival in the context of neurodegenerative diseases [5].
| DNAJB9 (ERdj4) |
|---|
| Gene Symbol | DNAJB9 |
| Full Name | DnaJ heat shock protein family (Hsp40) member B9 |
| Aliases | ERdj4, ERDJ4, Mom14, MDJ9 |
| Chromosomal Location | 9p24.1 |
| NCBI Gene ID | [23400](https://www.ncbi.nlm.nih.gov/gene/23400) |
| OMIM | [604037](https://www.omim.org/entry/604037) |
| Ensembl ID | ENSG00000102948 |
| UniProt ID | [Q9Y3X0](https://www.uniprot.org/uniprot/Q9Y3X0) |
| Associated Diseases | [ER Stress](/diseases/er-stress), [Unfolded Protein Response](/diseases/unfolded-protein-response), [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease) |
¶ Gene Structure and Protein Architecture
The DNAJB9 gene spans approximately 5.3 kb and consists of 5 exons. Alternative splicing generates multiple transcript variants, though the major isoform encodes a protein of 292 amino acids. The gene is located on chromosome 9p24.1, adjacent to other members of the DNAJ family.
¶ Protein Domains
The DNAJB9 protein contains three key functional domains:
-
N-terminal J domain (~70 amino acids): The hallmark DnaJ domain containing the highly conserved HPD motif. This domain interacts with Hsp70 family proteins (BiP/GRP78) and stimulates their ATPase activity.
-
Glycine/Phenylalanine-rich linker region (~50 amino acids): Flexible linker connecting the J domain to the substrate-binding domain.
-
C-terminal substrate-binding domain (~170 amino acids):CTerminal portion that binds unfolded proteins and helps prevent aggregation. Contains a conservedClient-binding region.
DNAJB9 is a key component of the ERAD pathway, which targets misfolded proteins for degradation by the proteasome:
- Substrate recognition: DNAJB9 identifies misfolded proteins in the ER lumen
- Handoff to BiP: The J domain facilitates substrate transfer to BiP (GRP78)
- Retrotranslocation: Misfolded proteins are translocated to the cytosol via the retrotranslocon (Sec61 or DER1)
- Ubiquitination: Substrates are ubiquitinated by E3 ubiquitin ligases (e.g., Hrd1, gp78)
- Proteasomal degradation: Tagged proteins are degraded by the 26S proteasome
DNAJB9 functions as a specialized co-chaperone for BiP (Binding immunoglobulin protein/GRP78), the major ER Hsp70:
- J domain function: Stimulates BiP ATPase activity
- Substrate binding: Delivers folded/unfolding proteins to BiP
- Allosteric regulation: Modulates BiP substrate affinity
- Cycle regulation: Coordinates substrate entry and release
DNAJB9 plays a dual role in UPR signaling:
- As a UPR target gene: DNAJB9 is transcriptionally upregulated by all three UPR sensors (IRE1, PERK, ATF6)
- As a UPR modulator: DNAJB9 helps restore ER homeostasis by enhancing protein folding capacity
DNAJB9 shows broad but variable expression:
- High expression: Pancreas, spleen, thymus, lymph nodes
- Moderate expression: Brain, small intestine, liver, kidney, lung
- Low expression: Heart, skeletal muscle, colon
Within the central nervous system, DNAJB9 is expressed in:
- Neurons: Particularly in pyramidal neurons of the cortex and hippocampus
- Astrocytes: Moderate expression in glial fibrillary acidic protein (GFAP)-positive astrocytes
- Oligodendrocytes: Lower expression compared to neurons and astrocytes
- Microglia: Minimal baseline expression; upregulated upon activation
DNAJB9 is exclusively localized to the ER lumen, where it performs its chaperone functions. Its retention is mediated by the KDEL (Lys-Asp-Glu-Leu) receptor system, though DNAJB9 lacks a canonical KDEL motif, suggesting alternative retention mechanisms.
DNAJB9 is intimately connected to AD pathogenesis through multiple mechanisms:
- Aβ production: DNAJB9 expression is altered in response to Aβ accumulation
- ER stress: Aβ induces prolonged UPR activation
- Protein homeostasis: DNAJB9 helps manage Aβ-induced proteostatic stress
- clearance: ERAD may contribute to Aβ production and clearance pathways [6]
- Phosphorylated tau: ER stress correlates with tau hyperphosphorylation
- UPR activation: DNAJB9 upregulation reflects attempted neuroprotection
- Neurofibrillary tangles: Relationship to tangle-bearing neurons unclear
- UPR modulators: Drugs that enhance DNAJB9 expression may provide neuroprotection
- BiP activators: Enhancing BiP activity through DNAJB9 may restore proteostasis
- ERAD enhancers: Boosting degradation of misfolded proteins
DNAJB9 connects to PD through alpha-synuclein pathology:
- ER stress response: Alpha-synuclein aggregation triggers ER stress
- UPR activation: Persistent UPR in PD brains
- Protein clearance: ERAD contributes to synuclein turnover
- Dopaminergic neuron vulnerability: High protein biosynthetic load makes these neurons dependent on efficient ER quality control
Zebrafish and mouse models show that DNAJB9 knockdown exacerbates PD-like pathology, while overexpression provides protection [12].
- ER stress: Common feature in ALS motor neurons
- Protein aggregation: TDP-43 and SOD1 misfolding trigger UPR
- BiP depletion: ER chaperone capacity overwhelmed
- Polyglutamine aggregates: Induce ER stress
- Chaperone alterations: DNAJB9 and other ERdj proteins dysregulated
- Therapeutic target: Hsp40 family members being explored
- Misfolded prion protein: Triggers ER stress
- UPR activation: Common pathological feature
- Chaperone response: DNAJB9 upregulation observed
DNAJB9 protects neurons through several anti-apoptotic mechanisms:
- ER calcium regulation: Prevents ER calcium depletion
- Caspase activation: Inhibits caspase-12 (ER-specific caspase)
- CHOP regulation: Modulates pro-apoptotic CHOP expression
- BiP stabilization: Maintains BiP availability
¶ Proteostasis Maintenance
The protein homeostasis network in neurons is particularly important due to:
- Long neuronal lifespan: Decades of protein synthesis
- Post-mitotic state: Cannot dilute damage through division
- High metabolic demand: Synaptic plasticity requires protein turnover
DNAJB9 helps maintain proteostasis by:
- Folding assistance: Reducing misfolded protein accumulation
- ERAD enhancement: Accelerating degradation of irreversibly damaged proteins
- UPR feedback: Modulating adaptive UPR responses
The ER is a major site of disulfide bond formation, and DNAJB9 assists in:
- Oxidative protein folding: Coordinating oxidative folding
- Redox homeostasis: Managing ER redox state
- ROS response: Protecting against oxidative stress
- BiP inducers: Boost BiP and co-chaperone expression
- ERAD modulators: Enhance misfolded protein clearance
- UPR modulators: Shift adaptive UPR responses
AAV-mediated DNAJB9 overexpression is being explored for:
- Neurodegeneration prevention
- ER stress reduction
- Protection against proteinopathies
DNAJB9 modulation may synergize with:
- Autophagy enhancers: e.g., rapamycin
- Proteasome activators: e.g., natural compounds
- Antioxidants: Reduce oxidative ER stress
DNAJB9 knockout mice show:
- Perinatal lethality: Some strains die in utero
- ER stress: Accumulation of misfolded proteins
- Impaired secretion: Reduced secretion of glycoproteins
- Developmental abnormalities: Particularly in secretory tissues
Zebrafish dnajb9 mutants display:
- Developmental defects: Craniofacial and pigment abnormalities
- ER dilation: Expanded ER cisternae
- Stress response: Constitutive UPR activation
DNAJB9 overexpression protects against:
- Tunicamycin-induced ER stress
- Thapsigargin toxicity
- Disease model phenotypes
flowchart TD
A["Misfolded<br/>Protein"] --> B["DNAJB9<br/>Recognition"]
B --> C["J Domain<br/>BiP Activation"]
C --> D["BiP<br/>Substrate Binding"]
D --> E["ERAD<br/>Complex"]
E --> F["Retrotranslocon<br/>Sec61/DER1"]
F --> G["Ubiquitination<br/>Hrd1/gp78"]
G --> H["Proteasomal<br/>Degradation"]
I["Properly Folded<br/>Protein"] --> J["Secretory<br/>Pathway"]
J --> K["Secretion<br/>or Membrane<br/>Insertion"]
L["ER Stress"] --> M["UPR<br/>Sensors"]
M --> N["DNAJB9<br/>Transcription"]
N --> B
O["Neurodegeneration"] --> P["ER Stress<br/>Accumulation"]
P --> Q["Protein<br/>Aggregation"]
Q --> R["Neuronal<br/>Death"]
style O fill:#ffcdd2
style R fill:#ef9a9a
style A fill:#ffecb3
style K fill:#c8e6c9
| Partner |
Function |
| BiP/GRP78 |
Primary Hsp70 co-chaperone substrate |
| GRP94 |
ER Hsp90 chaperone |
| ERdj3/DNAJB3 |
Co-chaperone function |
| ERdj5/DNAJC10 |
ERAD co-chaperone |
| PDI |
Protein disulfide isomerase |
- IRE1α pathway: Transcriptional regulation
- PERK pathway: eIF2α phosphorylation feedback
- ATF6 pathway: Golgi processing and activation
DNAJB9 expression may serve as:
- ER stress marker: In cerebrospinal fluid or blood
- Disease progression marker: Correlates with severity
- Therapeutic response marker: Drug target engagement
DNAJB9 polymorphisms have been associated with:
- Neurodegeneration susceptibility in some populations
- Age of onset modifiers in polyglutamine diseases
- Shen and Hendershot, ERdj5 and ERdj3 in protein folding (2005)
- Ohta and Sitia, ER chaperones in protein quality control (2008)
- Kane et al., DNAJB9/Mom14 in ER stress (2016)
- Liu and Li, DNAJB9 in unfolded protein response (2014)
- Chen et al., ERdj proteins in neurodegeneration (2019)
- Yun et al., DNAJB9 in Alzheimer's disease (2020)
- Park et al., DNAJ proteins in protein homeostasis (2018)
- Kimata et al., ER chaperone network (2008)